Frontier Medicines
- Total raised
- Series C
- Stage
- Series C
- Team size
- 51-200
- Founded
- 2018
- HQ
- South San Francisco
About Frontier Medicines
Frontier Medicines is a precision medicine company with offices in South San Francisco and Boston that uses chemoproteomics, covalent drug discovery, and machine learning to target disease-causing proteins previously undruggable; its lead p
Open roles · 5
- Open
Clinical Trial Manager
Boston · hybrid · $120k–150k
- Open
Vice President, Finance
Boston · on-site · $250k–310k
- Open
Vice President, Finance
San Francisco · on-site · $250k–310k
- Open
Director/Sr. Director, Clinical Operations - Oncology Programs
Boston · hybrid · $185k–250k
- Open
AI Engineer I
South San Francisco · on-site · $100k–159k
Location
More startups in South San Francisco
Cognition
San Francisco
The company is an applied AI lab that builds end-to-end software agents and collaborative AI teammates, enabling engineers to focus on more interesting problems and empowering teams to pursue ambitious goals; it markets Devin as the first A
Thinking Machines Lab
San Francisco
Thinking Machines Lab is a San Francisco AI research startup founded in 2025 by former OpenAI CTO Mira Murati, building interpretable, collaborative AI systems for professional and enterprise use. Its first product, Tinker, helps developers fine-tune models without managing distributed infrastructure.
Mind Robotics
Palo Alto
Mind Robotics develops artificial intelligence and robotics systems designed for industrial environments and manufacturing operations.
Xaira Therapeutics
South San Francisco
an integrated biotechnology company driving advances in AI to transform how we treat disease.
Poolside
San Francisco
Poolside is building the world's most capable AI for software development, focusing on distributed training and inference of large language models for source code generation, with a mission to unlock developers' potential through AI for sof
The Bot Company
San Francisco
The Bot Company builds household robots to give people back time, pursuing in-house AI, software and hardware. It plans to deploy millions at home before expanding, and has raised $300M, including a $150M Greenoaks-led round, valuing the co